BRD4 and leukemia: Genome-wide loss-of-function clustered regularly interspaced short palindromic repeats (CRISPR) screens identify SPOP gene deficiency as a resistance factor to BRD4 inhibitor therapy in KMT2A gene-rearranged leukemia cells [54].